Drug Type Synthetic peptide |
Synonyms |
Target- |
Mechanism Cell movement inhibitors, Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Allergic Contact | Phase 2 | - | - | |
Dermatitis, Allergic Contact | Phase 2 | - | - | |
Dermatitis, Contact | Phase 2 | - | - |